PGX-200097

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NamePGX-200097

Drug Alias NameCOMT/dopamine D2 receptor inhibitors (Psychiatric Genomics)catechol-O-methyltransferase/dopamine D2 receptor inhibitors (Psychiatric Genomics)PGX-200097

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCatechol-O-methyl transferase inhibitorsDopamine D2 receptor antagonists

TargetsCatechol-O-methyl transferaseDopamine D2 receptor

Therapy Area/IndicationsSchizophrenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPsychiatric Genomics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPsychiatric Genomics Inc

Active IndicationsN/A

Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A